Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction

Epidemiology and Infection

Volumn 141, Issue 9, 2013, Pages 1787-1796

  Georges, S ^a   Lepoutre, A ^a   Dabernat, H ^b   Levy Bruhl, D ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

epidemiology; France; Haemophilus influenzae; meningitis; vaccination

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

AGE DISTRIBUTION; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG SAFETY; FRANCE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS MENINGITIS; HIGH RISK POPULATION; HUMAN; IMMUNOGENICITY; INCIDENCE; PREVALENCE; REVIEW; VACCINATION;

BACTEREMIA; FRANCE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; MENINGITIS, HAEMOPHILUS;

EID: 84881473631     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813000083     Document Type: Review

References (33)

1. Decker MD, et al. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. Journal of Pediatrics 1992; 120: 184-189.
2. Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340: 592-594.
3. Anon. The immunization schedule. Bulletin Epidemiologique Hebdomadaire 1993; 1: 1-2.
4. Boucher J, et al. Epidemiology of Haemophilus influenzae b infections in 2 French districts. Bulletin Epidemiologique Hebdomadaire 1992; 1: 1-2.
5. Dabernat H, Delmas C. Haemophilus influenzae, b serotype and the others. Bulletin Epidemiologique Hebdomadaire 1994; 7: 31-32.
6. Roure C, Begue P. Vaccination against Haemophilus influenzae type b. Recommendations of the Technical Committee on Immunization. Bulletin Epidemiologique Hebdomadaire 1992; 18: 77-78.
7. Georges S, et al. Sixteeen years of surveillance of bacterial invasive infections in France (1991-2006) through the EPIBAC network. Revue Francophone des Laboratoires 2008; 407: 35-43.
8. Falla TJ, et al. PCR for capsular typing of Haemophilus influenzae. Journal of Clinical Microbiology 1994; 32: 2382-2386. (Pubitemid 24284632)
9. Dabernat H, et al. Bacterial meningitis in France. Study in 6 mainland districts in 1995-1997. Medecine et Maladies Infectieuses 2000; 30: 588-594.
10. Dabernat H, Delmas C. Activities of the National Reference Centre for Haemophilus influenzae, 1994-1995. First post-vaccination years. Medecine et Maladies Infectieuses 1996; 26: 698-703.
11. Dabernat H, Delmas C. Activities of the National Reference Centre for Haemophilus influenzae, 1996-1997: The decline of the b type. Medecine et Maladies Infectieuses 1998; 28: 940-946. (Pubitemid 29042322)
12. Dabernat H, et al. Genotyping of type b Haemophilus influenzae strains, comparison of strains collected before and during vaccine availability. Medecine et Maladies Infectieuses 2005; 35: 205-212. (Pubitemid 40725150)
13. Fonteneau L, Guthmann JP, Levy-Bruhl D. Estimations of vaccination coverage at 24 months of age through the health certificates-2004-2007. Report of the Institut de veille sanitaire, 2010 (http://www.invs.sante. fr/publications/).
14. Ribeiro GS, et al. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine 2007; 22: 4420-4428. (Pubitemid 46695803)
15. Ladhani SN. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom. Clinical Therapeutics Journal. 2012; 34: 385-399.
16. Miranzi Sde S, de Moraes SA, de Freitas IC. Impact of the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil. Cadernos de Saude Publica. 2007; 23: 1689-1695.
17. Heath PT, McVernon J. The UK Hib vaccine experience. Archives of Disease in Childhood. 2002; 86: 396-399. (Pubitemid 34596646)
18. Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatric Infectious Disease Journal. 1998; 17 (Suppl. 9):132-136.
19. Ladhani S, et al. Invasive Haemophilus influenzae disease, Europe, 1996-2006. Emerging Infectious Diseases 2010; 16: 455-463.
20. Barbour ML, Mayon-White RT. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. Journal of Infectious Diseases 1995; 171: 93-98.
21. McVernon J, et al. Trends in Haemophilus influenzae type b infections in adults in England and Wales: Surveillance study. British Medical Journal 2004; 329: 655-658. (Pubitemid 39279284)
22. Dabernat H, et al. Haemophilus influenzae carriage in children attending French day care centers: A molecular epidemiological study. Journal of Clinical Microbiology 2003; 41: 1664-1672. (Pubitemid 36428115)
23. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons 565 years old. Clinical Infectious Diseases 2007; 44: 810-816. (Pubitemid 46365305)
24. Takala AK, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 1991; 164: 982-986.
25. Ladhani S, et al. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infectious Disease 2008; 8: 275-276. (Pubitemid 351615751)
26. McVernon J, Ramsay ME, McLean AR. Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom. Epidemiology and Infection 2008; 136: 800-812. (Pubitemid 351524015)
27. Bajanca P, Caniça M, and the Multicenter Study Group. Emergence of non-encapsulated and encapsulated non-type-b invasive Haemophilus influenzae isolates in Portugal 1989-2001. Journal of Clinical Microbiology 2004; 42: 807-810. (Pubitemid 38222666)
28. Ribeiro GS, et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. Journal of Infectious Diseases 2003; 187: 109-116. (Pubitemid 36034478)
29. Hubert B, Goulet V, Rioux JY. Surveillance of meningococcal disease in France1990-7. Eurosurveillance 1997; 10: 78-79.
30. Perrocheau A. Evaluation of meningococcal infections surveillance in 1996 through the capture-recapture method. Report of the Institut de veille sanitaire, 2001 (http://www.invs.sante.fr/publications/).
31. Perrocheau A. Surveillance of meningococcal invasive infections in France in 2000. Quantitative evaluation through the 3 sources capture-recapture method. Report of the Institut de veille sanitaire, 2006 (http://www.invs.sante. fr/publications/).
32. Berger F, et al. Surveillance of meningococcal invasive infections in France in 2005. Quantitative evaluation through the 3 sources capture-recapture method. Report of the Institut de veille sanitaire, 2010 (http://www.invs. sante.fr/publications/).
33. Peltola H. Haemophilus influenzae type b disease and vaccination in Europe: Lessons learned. Pediatric Infectious Disease Journal. 1998; 17 (Suppl.9): 126-132.